ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,325Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 2094

$1.14M Total Retail Price of All Prescriptions

Rank: 64 out of 2094

597 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 597 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

2% of this provider’s 597 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 12,959 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 601 577 1 2
SIMVASTATIN 563 505 2 1
LEVOTHYROXINE SODIUM 428 381 3 3
OMEPRAZOLE 408 378 4 4
DIOVAN HCT 385 337 5 28
FUROSEMIDE 353 301 6 6
METFORMIN HCL 340 296 7 8
ATORVASTATIN CALCIUM 322 300 8 5
NEXIUM 295 260 9 16
DONEPEZIL HCL 272 271 10 20
CARVEDILOL 260 238 11 19
METOPROLOL SUCCINATE 244 237 12 9
ALENDRONATE SODIUM 238 212 13 30
AZITHROMYCIN 227 190 14 27
GLIMEPIRIDE 207 202 15 31
ZOLPIDEM TARTRATE 202 182 16 14
SERTRALINE HCL 191 182 17 26
MELOXICAM 189 177 18 49
CRESTOR 188 172 19 15
DIOVAN 188 165 19 13
JANUVIA 185 185 21 35
POTASSIUM CHLORIDE 180 166 22 24
METOPROLOL TARTRATE 146 111 23 10
LEVOFLOXACIN 134 124 24 70
LIPITOR 130 128 25 39
NAMENDA 126 126 26 32
CLOPIDOGREL 121 117 27 22
PLAVIX 119 113 28 38
LISINOPRIL 118 107 29 7
PROAIR HFA 109 83 30 45
LOSARTAN-HYDROCHLOROTHIAZIDE 106 106 31 52
BENICAR 104 103 32 108
MECLIZINE HCL 103 93 33 103
ALLOPURINOL 101 98 34 50
LOVAZA 99 85 35 53
ACTONEL 97 86 36 151
HYDROCHLOROTHIAZIDE 96 78 37 12
LOSARTAN POTASSIUM 94 88 38 17
NAPROXEN 92 78 39 84
METFORMIN HCL ER 89 80 40 67
ATENOLOL 86 86 41 21
AMLODIPINE BESYLATE-BENAZEPRIL 86 86 41 58
FENOFIBRATE 85 70 43 104
LEVOCETIRIZINE DIHYDROCHLORIDE 85 80 43 169
LYRICA 85 83 43 85
TRICOR 84 55 46 99
BENICAR HCT 83 78 47 133
ADVAIR DISKUS 81 76 48 36
WARFARIN SODIUM 77 77 49 11
PRAVASTATIN SODIUM 74 52 50 18
SYNTHROID 74 74 50 44
CLONIDINE HCL 73 73 52 62
TAMSULOSIN HCL 73 71 52 29
CELEBREX 73 66 52 74
VOLTAREN 69 67 55 109
CLOTRIMAZOLE-BETAMETHASONE 69 61 55 91
SYMBICORT 67 50 57 149
PAROXETINE HCL 67 60 57 77
ENALAPRIL MALEATE 65 65 59 25
SINGULAIR 64 54 60 64
IBANDRONATE SODIUM 64 64 60 140
EXELON 62 62 62 111
LIDODERM 61 59 63 59
LANTUS 58 52 64 66
RAMIPRIL 58 57 64 48
TRAMADOL HCL 58 58 64 33
LANTUS SOLOSTAR 54 47 67 76
PANTOPRAZOLE SODIUM 53 40 68 37
VALSARTAN-HYDROCHLOROTHIAZIDE 53 43 68 225
FLUTICASONE PROPIONATE 52 39 70 41
KLOR-CON M10 51 35 71 190
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 17, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.